| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| (2R,6R)-4-(tert-butoxycarbonyl)-6-MethylMorpholine-2-carboxylic acid |
(2R,6R)-4-(叔丁氧基羰基)-6-甲基嗎啉-2-羧酸 |
1581752-93-3 |
詳細(xì)
|
| (2R, 4S)-4-Hydroxy-2-methyl-pyrrolidine-1-carboxylic acid tert-butyl ester |
(2R,4S)-4-羥基-2-甲基-吡咯烷-1-甲酸叔丁酯 |
348165-62-8 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-BIBOP |
(2S,2'S,3S,3'S)-3,3'-雙(1,1-二甲基乙基)-2,2',3,3'-四氫-2,2'-雙-1,3-苯并氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1202033-17-7 |
詳細(xì)
|
| Valganciclovir hydrochloride |
(2S)-2-((2-氨基-6-氧代-1H-嘌呤-9(6H)-基)甲氧基)-3-羥丙基 2-氨基-3-甲基丁酸酯鹽酸鹽 |
175865-59-5 |
詳細(xì)
|
| (S,S)-(-)-2,3-DIHYDROXY-N,N,N',N'-TETRAMETHYLSUCCINAMIDE |
N,N,N,N-四甲基-d-酒石酰胺 |
63126-52-3 |
詳細(xì)
|
| (2S,3S)-2-Amino-3-methoxybutanoic acid |
(2S,3S)--2-氨基-3-甲氧基丁酸 |
104195-80-4 |
詳細(xì)
|
| 5-Bromo-4-chloro-3-indolyl-beta-D-glucoside |
5-溴-4-氯-3-吲哚基-beta-D-吡喃葡萄糖苷 |
15548-60-4 |
詳細(xì)
|
| 4,?4'-?Bi-?1,?3-?benzoxaphosphole, 3,?3'-?bis(1,?1-?dimethylethyl)?-?2,?2'-?diethyl-?2,?2',?3,?3'-?tetrahydro-?, (2R,?2'R,?3R,?3'R)?-?rel- |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2'-二乙基-2,2',3,3'-四氫-4,4'-二苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
2415751-83-4 |
詳細(xì)
|
| 2,3,5,4＇-Tetrahydroxy stilbene-2-Ο-β-D-glucoside |
2,3,5,4'-四羥基二苯乙烯-2-O-β-D-葡萄糖苷 |
82373-94-2 |
詳細(xì)
|
| (2S-trans)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic acid |
(2S,3S)-3-氨基-2-甲基-4-氧代氮雜環(huán)丁烷-1-磺酸 |
80082-65-1 |
詳細(xì)
|
| (2S)-1-[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene |
(2S)-1-[(4R)-4,5-二氫-4-苯基-2-惡唑基]-2-(二苯基膦基)二茂鐵 |
291536-01-1 |
詳細(xì)
|
| (2S,3S)-3-(tert-butyl)-4-(2,
6-dimethoxyphenyl)-2-met
hyl-2,3-dihydrobenzo[d][1,
3]oxaphosphole |
(2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-甲基-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1373432-11-1 |
詳細(xì)
|
| (2S)-2-AMINO-2-(2,5-DICHLOROPHENYL)ETHAN-1-OL HYDROCHLORIDE |
(2S)-2-氨基-2-(2,5-二氯苯基)乙醇鹽酸鹽 |
1391487-11-8 |
詳細(xì)
|
| trans-4-Hydroxy-D-proline |
(2R,4S)-4-羥基吡咯烷-2-羧酸 |
3398-22-9 |
詳細(xì)
|
| (2S,3S)-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole |
(2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-乙基-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
2247162-97-4 |
詳細(xì)
|
| (2S)-2-AMINO-2-(2-ANTHRYL)ETHAN-1-OL |
(2S)-2-氨基-2-(2-蒽基)乙-1-醇 |
1213581-06-6 |
詳細(xì)
|
| (2R,4S)-1-BOC-4-AMINO-PYRROLIDINE-2-CARBOXYLIC ACID |
(2R,4S)-4-氨基-1-(叔丁氧基羰基)吡咯烷-2-羧酸 |
132622-78-7 |
詳細(xì)
|
| (2S,3S)-3-AMINOPENTAN-2-OL HYDROCHLORIDE |
(2S,3S)-3-氨基戊烷-2-醇鹽酸鹽 |
1352149-50-8 |
詳細(xì)
|
| N-Boc-Trans-4-Hydroxy-D-proline methyl ester |
N-BOC-(2R,4S)--4-羥基-D-脯氨酸甲酯 |
135042-17-0 |
詳細(xì)
|
| Z-ILE-ILE-OH |
(2S,3S)-2-((2S,3S)-2-(((芐氧基)羰基)氨基)-3-甲基戊酰氨基)-3-甲基戊酸 |
42538-01-2 |
詳細(xì)
|
| (S,S)-(+)-2,3-DIMETHOXY-1,4-BIS(DIMETHYLAMINO)BUTANE |
(2S,3S)-2,3-二甲氧基-N1,N1,N4,N4-四甲基丁烷-1,4-二胺 |
26549-21-3 |
詳細(xì)
|
| (R)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline |
(4R)-4-叔丁基-2-[(2S)-2-(二苯基膦基)二茂鐵基]-2-噁唑啉 |
1226898-27-6 |
詳細(xì)
|
| trans 1-CBZ-2-METHYL-PIPERIDIN-4-OL |
(2R,4S)-rel-4-羥基-2-甲基哌啶-1-羧酸叔丁酯 |
152491-46-8 |
詳細(xì)
|
| Vildagliptin IMpurity 2 (Mixture of DiastereoMers) |
(2S,2'S)-1,1'-(2,2'-((3-羥基金剛烷-1-基)氮烷二基)雙(乙?；?)二(吡咯烷-2-腈) |
1036959-23-5 |
詳細(xì)
|
| (2S,3S)-α2,α2,α3,α3-tetraphenyl-1,4-Dioxaspiro[4.5]decane-2,3-diMethanol |
(2S,3S)-1,4-二氧雜螺[4.5]癸烷-2,3-二基雙(二苯基甲醇) |
123287-35-4 |
詳細(xì)
|
| N-CBZ-trans-4-Hydroxy-D-prolinol |
(2R,4S)-4-羥基-2-(羥甲基)吡咯烷-1-羧酸芐酯 |
1448706-36-2 |
詳細(xì)
|
| (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
(2s)-順-羥基內(nèi)酰胺 |
42399-49-5 |
詳細(xì)
|
| (2S)-benzyl 2-((chloro(phenoxy)phosphoryl)amino)propanoate(WXC06864) |
(2S)-2-((氯(苯氧基)磷?；?氨基)丙酸芐酯 |
183370-70-9 |
詳細(xì)
|
| (2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole |
(2S,3S)-4-(蒽-9-基)-3-(叔丁基)-2-異丙基-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1891002-61-1 |
詳細(xì)
|
| (+)-DIHYDROCARVONE MIXTURE OF ISOMERS |
(2R,5R)-2-甲基-5-(丙-1-烯-2-基)環(huán)己酮 |
5524-05-0 |
詳細(xì)
|
| (S)-(+)-3-Chloro-1,2-propanediol |
(S)-(+)-3-氯丙基-1,2-二醇 |
60827-45-4 |
詳細(xì)
|
| (2S)-1-[(4R)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-(diphenylphosphino)ferrocene |
(2S)-1-[(4R)-4,5-二氫-4-(1-甲基乙基)-2-噁唑基]-2-(二苯基膦基)二茂鐵 |
1065474-88-5 |
詳細(xì)
|
| 1,3-Dioxolane, 2-[2-[(2R,5R)-2,5-diethyl-1-phospholanyl]phenyl]- |
(2R,5R)-1-(2-(1,3-二氧戊環(huán)-2-基)苯基)-2,5-二乙基磷雜環(huán)戊烷 |
1710765-27-7 |
詳細(xì)
|
| 1-Cyclopentene-1-propanoic acid, α-amino-, (αS)- |
(2S)-2-氨基-3-(環(huán)戊-1-烯-1-基)丙酸 |
1932577-35-9 |
詳細(xì)
|
| (2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate |
(2R,4S)-1-Boc-4-氨基-2-吡咯烷甲酸甲酯 |
254881-77-1 |
詳細(xì)
|
| 10-Propargyl-10-deazaaminopterin |
(2S)-2-(4-(1-(2,4-二氨基喋呤-6-基)戊-4-炔-2-基)苯甲酰胺基)戊二酸 |
146464-95-1 |
詳細(xì)
|
| (2R,4S)-4-{[(tert-butoxy)carbonyl]amino}pyrrolidine-2-carboxylic acid |
(2R,4S)-4-((叔丁氧基羰基)氨基)吡咯烷-2-羧酸 |
1279030-48-6 |
詳細(xì)
|
| (2R,4S)-benzyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate |
(2R,4S)-4-氨基-2-(羥基甲基)吡咯烷-1-羧酸芐酯 |
1279200-14-4 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-MeO-BIBOP |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2',3,3'-四氫-4,4'-二甲氧基-2,2'-雙-1,3-苯并氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1202033-19-9 |
詳細(xì)
|
| Z-MEILE-OH |
(2S,3S)-2-(芐基(甲基)氨基)-3-甲基戊酸 |
4125-97-7 |
詳細(xì)
|
| 1,?3-?Benzoxaphosphole, 3-?(1,?1-?dimethylethyl)?-?2,?3-?dihydro-?4-?(2-?methoxyphenyl)?-?2-?(1-?methylethyl)?-?, (2S,?3S)?- |
(2S,3S)-3-(叔丁基)-2-異丙基-4-(2-甲氧基苯基)-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
2565792-33-6 |
詳細(xì)
|
| 1-Piperidinecarboxylicacid,4-hydroxy-2-methyl-,1,1-dimethylethylester,(2R,4R)-(9CI) |
(2R,4R)-4-羥基-2-甲基哌啶-1-羧酸叔丁酯 |
790667-44-6 |
詳細(xì)
|
| FMOC-ALLO-THR-OH |
(2S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-羥基丁酸 |
146306-75-4 |
詳細(xì)
|
| 2-{2-[(2R,5R)-2,5-dimethyl-1-phospholano]phenyl}1,3-dioxolane, min. 97% |
(2R,5R)-1-(2-(1,3-二氧戊環(huán)-2-基)苯基)-2,5-二甲基磷雜環(huán)戊烷 |
1044256-04-3 |
詳細(xì)
|
| (2R,5S)-1,2,5-triMethylpiperazine hydrochloride |
(2R,5S)-1,2,5-三甲基哌嗪鹽酸鹽 |
1046788-71-9 |
詳細(xì)
|
| BOC-(2S,3S)-3-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID |
N-Boc-(2S,3S)-3-羥基-2-羧基吡咯烷 |
187039-57-2 |
詳細(xì)
|
| (+)-DIPIVALOYL-D-TARTARIC ACID |
(+)-二特戊酰基-d-酒石酸 |
76769-55-6 |
詳細(xì)
|
| E-64C |
(2S,3S)-3-(((S)-1-(異戊基氨基)-4-甲基-1-氧代戊烷-2-基)氨甲酰)環(huán)氧乙烷-2-羧酸 |
76684-89-4 |
詳細(xì)
|
| (2S,3S)-2-benzyl-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole |
(2S,3S)-2-芐基-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1373432-13-3 |
詳細(xì)
|
| BOC-OIC-OH |
(2S,3aS,7aS)-1-(叔丁氧羰基)八氫-1H-吲哚-2-羧酸 |
109523-13-9 |
詳細(xì)
|
| L-Glutamic acid, N,N'-(1,16-dioxo-1,16-hexadecanediyl)bis- |
(2S,2'S)-2,2'-(十六烷二?；p(氮雜二基))二戊二酸 |
1255861-91-6 |
詳細(xì)
|
| (5R,2S)-2,5-Diaminoadipic acid 2HCl |
(5R,2S)-2,5-二氨基乙二酸二鹽酸鹽 |
213686-09-0 |
詳細(xì)
|
| 1,3,4,6-Tetra-O-acetyl-a-D-glucosamineHCI |
1,3,4,6-四-O-乙酰基-2-氨基-2-脫氧-β-D-葡萄糖鹽酸鹽 |
10034-20-5 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-4,4'-di(anth
racen-9-yl)-3,3'-di-tert-but
yl-2,2',3,3'-tetrahydro-2,2'-
bibenzo[d][1,3]oxaphosph
ole |
(2S,2'S,3S,3'S)-4,4'-二(蒽-9-基)-3,3'-二叔丁基-2,2',3,3'-四氫-2,2'-聯(lián)苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1435940-19-4 |
詳細(xì)
|
| 2-[[(2R)-2-[(2R)-1-(pyridin-2-ylmethyl)pyrrolidin-2-yl]pyrrolidin-1-yl]methyl]pyridine:tetrahydrochloride |
(2S,2'S)-[N,N'-雙(2-吡啶甲基)]-2,2'-聯(lián)吡咯烷四鹽酸鹽 |
1285550-13-1 |
詳細(xì)
|
| 1,2,3,4-TETRA-O-ACETYL-BETA-D-XYLOPYRANOSE |
1,2,3,4-四-o-乙酰-β-d-吡喃木糖 |
4049-33-6 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2'-二異丙基-2,2',3,3'-四氫-4,4'-二苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
2207601-12-3 |
詳細(xì)
|
| (2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-methyl-2,3-dihydrobenzo[d][1,3]oxaphosphole |
(2S,3S)-4-(蒽-9-基)-3-(叔丁基)-2-甲基-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1884594-02-8 |
詳細(xì)
|
| 5-Methyltetrahydrofolic acid |
(2S)-2-(4-((2-氨基-5-甲基-4-氧代-3,4,5,6,7,8-六氫蝶呤-6-基)甲基)氨基)苯甲酰胺)戊二酸 |
134-35-0 |
詳細(xì)
|
| H-MEILE-OH |
N-甲基L-異亮氨酸 |
4125-98-8 |
詳細(xì)
|
| (2R,5R)-1-{[(2R,5R)-2,5-Diethylpyrrolidin-1-yl]methylene}-2,5-diethylpyrrolidinium tetrafluoroborate, min. 97% |
(2R,5R)-1-{[(2R,5R)-2,5-二乙基吡咯烷-1-基]亞甲基}-2,5-二乙基吡咯烷鎓 |
1204324-20-8 |
詳細(xì)
|
| (2R,5R)-5-Benzyl-3-Methyl-2-(5-Methyl-2-furyl)-4-iMidazolidinone |
(2R,5R)-5-芐基-3-甲基-2-(5-甲基呋喃-2-基)咪唑烷-4-酮 |
877303-84-9 |
詳細(xì)
|
| (R)-1-[(S)-2-[DI(2-FURYL)PHOSPHINO]FERROCENYL]ETHYLDI(3,5-XYLYL)PHOSPHINE |
(S)-1-{(1S)-2-[二(2-呋喃基)膦基]二茂鐵基}乙基二(3,5-二甲苯基)膦 |
649559-66-0 |
詳細(xì)
|
| (2R,5R)-tert-butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate |
(2R,5R)-5-(羥甲基)-2-甲基哌嗪-1-羧酸叔丁酯 |
1403898-64-5 |
詳細(xì)
|
| (2R,6S)-tert-butyl 2,6-dimethylmorpholine-4-carboxylate |
(2R,6S)-2,6-二甲基嗎啉-4-甲酸叔丁酯 |
1599378-89-8 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-Ph-BIBOP |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-4,4'-二苯基-2,2',3,3'-四氫-2,2'-二苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1202033-21-3 |
詳細(xì)
|
| (2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole |
(2S,3S)-4-(蒽-9-基)-3-(叔丁基)-2-乙基-2,3-二氫苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1884594-03-9 |
詳細(xì)
|
| (2S,2'S)-2,2'-(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl)dipropanoic acid |
(2S,2'S)-2,2'-(1,3,6,8-四氧代-1,3,6,8-四氫苯并[lmn][3,8]菲咯啉-2,7-二基)二丙酸 |
429692-85-3 |
詳細(xì)
|
| Diethyl meso-2,5-dibromoadipate |
(2R,5S)-rel-2,5-二溴己二酸二乙酯 |
54221-37-3 |
詳細(xì)
|
| (2R,5R)-1,6-Diphenylhexane-2,5-diaMine dihydrochloride |
(2R,5R)-1,6-二苯基己烷-2,5-二胺二鹽酸鹽 |
1247119-31-8 |
詳細(xì)
|
| (2R,4S)-Methyl 4-((tert-butoxycarbonyl)aMino)pyrrolidine-2-carboxylate hydrochloride |
(2R,4S)-4-Boc-氨基吡咯烷-2-羧酸甲酯鹽酸鹽 |
1279032-67-5 |
詳細(xì)
|
| Diltiazem hydrochloride |
(2S,3S)-5-(2-(二甲胺基)乙基)-2-(4-甲氧基苯基)-4-氧代-2,3,4,5-四氫苯并[b][1,4]硫氮雜卓-3-基 乙酸酯鹽酸鹽 |
33286-22-5 |
詳細(xì)
|
| N-Glycyl-L-isoleucine |
(2S,3S)-2-(2-氨基乙酰氨基)-3-甲基戊酸 |
19461-38-2 |
詳細(xì)
|
| (2R,4S)-N-ALPHA-T-BUTOXYCARBONYL-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID |
N-Boc-反式-4-羥基-D-脯氨酸 |
147266-92-0 |
詳細(xì)
|
| (2S)-2-(4-chlorophenyl)piperidine hydrochloride |
(2S)-2-(4-氯苯基)哌啶鹽酸鹽 |
1391375-27-1 |
詳細(xì)
|
| Di-p-anisoyl-D-tartaric acid |
D-二對(duì)甲氧基苯甲酰酒石酸 |
191605-10-4 |
詳細(xì)
|
| (2S,3S)-3-methylpent-4-en-3-ol |
(2S,3S)-3-甲基戊-4-烯-2-醇 |
99438-31-0 |
詳細(xì)
|
| Phospholane, 1-hydroxy-2,5-diphenyl-, 1-oxide, (2R,5R)- |
(2R,5R)-1-羥基-2,5-二苯基磷雜環(huán)戊烷 1-氧化物 |
226393-33-5 |
詳細(xì)
|
| (2S)-1-[(4R)-4,5-Dihydro-4-phenylmethyl-2-oxazolyl]-2-(diphenylphosphino)ferrocene |
(2S)-1-[(4R)-4,5-二氫-4-苯基-2-惡唑基]-2-(二苯基膦基)二茂鐵 |
2256046-71-4 |
詳細(xì)
|
| Di-o-toluoyl-D-tartaric acid |
(2S,3S)-2,3-二((2-甲基苯甲酰)氧基)琥珀酸 |
391624-66-1 |
詳細(xì)
|
| (2R,4S)-4-Alloc-aMino-1-FMoc-Pyrrolidine-2-carboxylic acid |
(2R,4S)-1-(((9H-芴-9-基)甲氧基)羰基)-4-(((烯丙氧基)羰基)氨基)吡咯烷-2-羧酸 |
549534-58-9 |
詳細(xì)
|
| (2R,4S)-4-AMINO-1-BOC-PYRROLIDINE-2-CARBOXYLIC ACID METHYL ESTER-HCl |
(2R,4S)-N-Boc-4-氨基吡咯烷-2-羧酸甲酯鹽酸鹽 |
1217446-43-9 |
詳細(xì)
|
| Sacubitril Impurity 7 |
(2R,4S)-5-([1,1'-聯(lián)苯]-4-基)-4-(3-羧酰氨基)-2-甲基戊酸 |
149709-44-4 |
詳細(xì)
|
| (2R,5S)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
(2R,5S)-2,5-二甲基哌嗪-1-甲酸叔丁酯 |
309915-46-6 |
詳細(xì)
|
| BOC-HYP-OH DCHA |
Boc-反式-4-羥基-L-脯氨酸二環(huán)己胺鹽 |
21157-12-0 |
詳細(xì)
|
| (2R,5R)-(+)-2-TERT-BUTYL-3-METHYL-5-BENZYL-4-IMIDAZOLIDINONE |
(2R,5R)-2-叔丁基-3-甲基-5 芐基-4-咪唑啉酮 |
390766-89-9 |
詳細(xì)
|
| (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2'-二甲基-2,2',3,3'-四氫-4,4'-聯(lián)二苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
2207601-10-1 |
詳細(xì)
|
| Oxirane, 2-[2-(phenylmethoxy)ethyl]-, (2S)- |
(2S)-2-[2-(芐氧基)乙基]環(huán)氧乙烷 |
85960-55-0 |
詳細(xì)
|
| (2R,5R)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
(2R,5R)-2,5-二甲基-1-哌嗪甲酸叔丁酯 |
1240586-48-4 |
詳細(xì)
|
| t-Butyl(2R,5S)-2,5-dimethylpiperazine-1-carboxylate |
(2R,5S)-rel-2,5-二甲基哌嗪-1-甲酸叔丁酯 |
194032-41-2 |
詳細(xì)
|
| lithospermic acid |
(2S,3S)-4-((E)-3-((R)-1-羧基-2-(3,4-二羥基苯基)乙氧基)-3-氧代丙烷-1-烯-1-基)-2-(3,4-二羥基苯基)-7-羥基-2,3-二氫苯并呋喃-3-羧酸 |
28831-65-4 |
詳細(xì)
|
| (2R,5R)-2,5-HEXANEDIOL |
(2R,5R)-2,5-己二醇 |
17299-07-9 |
詳細(xì)
|
| (2R,4S)-N-BOC-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID METHYL ESTER |
(2R,4S)-N-Boc-4-羥基哌啶-2-甲酸甲酯 |
321744-26-7 |
詳細(xì)
|
| BOC-3-(3'-QUINOLYL)-L-ALANINE |
(2S)-2-{[(叔丁氧基)羰基]氨基}-3-(喹啉-3-基)丙酸 |
135101-20-1 |
詳細(xì)
|
| tert-butyl-4-(2,6-dimethoxyphenyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-4-(2,6-dimethoxyphenyl)- |
(2S,2'S,3S,3'S)-3,3'-二叔丁基-4,4'-雙(2,6-二甲氧基苯基)-2,2',3,3'-四氫-2,2'-二苯并[d][1,3]氧磷雜環(huán)戊二烯/ 賾軍醫(yī)藥授權(quán)銷(xiāo)售 |
1435940-21-8 |
詳細(xì)
|
| (2R,5R)-(+)-BIS(DIPHENYLPHOSPHINO)HEXANE |
(2R,5R)-己烷-2,5-二基雙(二苯基膦) |
142494-67-5 |
詳細(xì)
|
| LY 345899) |
(2S)-2-(4-(3-氨基-1,9-二氧代-1,2,5,6,6a,7-六氫咪唑并[1,5-f]蝶啶-8(9H)-基)苯甲酰胺基)戊二酸 |
10538-99-5 |
詳細(xì)
|
| Josiphos SL-J216-2 |
(2S)-1-[(1S)-1-[雙(1,1-二甲基乙基)膦基]乙基]-2-(二-1-萘基膦基)二茂鐵 |
849924-44-3 |
詳細(xì)
|
| FMOC-3-(3'-QUINOLYL)-L-ALANINE |
(2S)-2-([(9H-芴-9-基甲氧基)羰基]氨基)-3-(喹啉-3-基)丙酸 |
281655-61-6 |
詳細(xì)
|
| (2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester |
(1R,2S,5R)-5-甲基-2-異丙基環(huán)己酯 |
147126-62-3 |
詳細(xì)
|